Product Information
DROSP-EE-LEVOMEF 3-0.03-0.451 is a generic product labeled by Sandoz Inc., priced at $2.9093 per EA under NDC 00781410315. Its NADAC has been published 175 times since Sep 23, 2020.
FDA first approved this application on Dec 16, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DROSP-EE-LEVOMEF 3-0.03-0.451
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calciumManufacturer
Sandoz Inc.NDC
00781410315
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA022574FDA Approved
12/16/2010
TE Code
AB
On Market Since
8/1/2015
Price Statistics
The NADAC for DROSP-EE-LEVOMEF 3-0.03-0.451 has been published 175 times since Sep 23, 2020, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9093 per EA |
|---|---|
| All-time high | $4.5983 (Sep 15, 2021) |
| All-time low | $2.9093 (Aug 19, 2026) |
| 52-week high | $3.4930 |
| 52-week low | $2.9093 |
| Median price | $3.3447 |
| Average price | $3.6562 |
| Largest weekly change | -22.1% (Apr 17, 2024) |
| Weeks tracked | 175 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROSP-EE-LEVOMEF 3-0.03-0.451?
The current National Average Drug Acquisition Cost (NADAC) for DROSP-EE-LEVOMEF 3-0.03-0.451, manufactured by Sandoz Inc., is $2.9093 per EA (NDC 00781410315), effective Aug 19, 2026.
How has the price of DROSP-EE-LEVOMEF 3-0.03-0.451 changed over time?
Over the history we have for it, the NADAC for DROSP-EE-LEVOMEF 3-0.03-0.451 has declined 36.7%. It has been tracked across 175 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for DROSP-EE-LEVOMEF 3-0.03-0.451?
Since Sep 23, 2020, the NADAC for DROSP-EE-LEVOMEF 3-0.03-0.451 has ranged from a low of $2.9093 (Aug 19, 2026) to a high of $4.5983 (Sep 15, 2021), with a median of $3.3447 per EA.
Are there cheaper alternatives to DROSP-EE-LEVOMEF 3-0.03-0.451?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROSP-EE-LEVOMEF 3-0.02-0.451, is $1.4023 per EA — about 52% below DROSP-EE-LEVOMEF 3-0.03-0.451.
Who manufactures DROSP-EE-LEVOMEF 3-0.03-0.451?
DROSP-EE-LEVOMEF 3-0.03-0.451 (NDC 00781410315) is labeled by Sandoz Inc., and CMS classifies it as a generic product.